SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today reported financial and operating results for the quarter and year ended December 31, 2006. Key financial results for the 2006 fourth quarter included:
